ACEA 1021 glystasin targeted to the glycine binding site on the excitatory calcium channel-NMDA receptor complex: Will begin a U.S. Phase I/II dose-escalation s

CoCensys Inc. (COCN), Irvine, Calif. Product: ACEA 1021 glystasin targeted to the glycine binding site on the excitatory calcium channel- NMDA receptor complex Indication: Stroke Status: Will begin a ...